Obscure hair loss topicals like Alfatradiol, Fluridil, and Stemoxydine are discussed. They may be considered for those not responding well to common treatments like Minoxidil and Finasteride.
A user shared their hair loss journey, starting with minoxidil and later switching to finasteride due to dissatisfaction with minoxidil. They experienced some regrowth and shedding, with mild side effects from finasteride, and are hopeful for future improvements.
Hair loss therapies focusing on hair follicle sugar metabolism and aldose reductase. Potential treatments include magnesium supplements, avoiding high glycemic index foods, and antioxidants.
The conversation discusses DHT blocking treatments for hair loss, specifically mentioning Minoxidil, Finasteride, and organic flaxseed oil containing omega-3 fatty acids. It highlights skepticism about alternative treatments and emphasizes the proven effectiveness of Finasteride and Dutasteride.
User experienced side effects from oral finasteride and tried topical Alfatradiol for hair loss. Alfatradiol provided maintenance without significant regrowth, and user suggests it as an alternative for those struggling with finasteride side effects.
Hair loss treatments discussed include leave-in conditioner, volumizing powder, styling products, and hairspray for thicker appearance without fibers. User shares routine and product suggestions for people with thin hair that lacks volume.
A user's experience with hair loss treatments such as minoxidil and finasteride, which has resulted in positive results. Others have also shared their experiences with similar treatments with encouraging results.
A man's experience with hair loss, which has caused him to lose an important part of his identity, and the treatments he is using to try and combat it. Others have joined in the conversation to share their own experiences and offer support.
Treatments used to prevent and treat male pattern baldness, the difficulty in finding a permanent cure for hair loss, and the potential financial motivations of companies not wanting to find a cure.